Research ArticleTuberculosis

Direct inhibitors of InhA are active against Mycobacterium tuberculosis

See allHide authors and affiliations

Science Translational Medicine  07 Jan 2015:
Vol. 7, Issue 269, pp. 269ra3
DOI: 10.1126/scitranslmed.3010597

eLetters is an online forum for ongoing peer review. Submission of eLetters are open to all. Please read our Terms of Service before submitting your own eLetter.

Compose eLetter

Plain text

  • Plain text
    No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests
CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Image CAPTCHA
Enter the characters shown in the image.

Vertical Tabs

  • Tackling tuberculosis complexions

    The emergence of drug resistance in Mycobacterium tuberculosis bacilli, social stigma in TB patients and weak health care networks in remote rural areas are limiting factors in diagnosis and prognosis of TB where situation can be worsen when individuals are suffering with AIDS. Recently, Manjunatha et al 2015 (1) reports in Science Translational Medicine that synthetic compound NITD-916 specifically target Mycolic acid...

    Show More
    Competing Interests: None declared.